A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

S 5059 (119th Congress) is federal legislation introduced in the U.S. Senate. Current status: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (2026-07-21).